找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affect; Proceedings of the T Joel Morganroth,

[復(fù)制鏈接]
樓主: CLIP
31#
發(fā)表于 2025-3-27 00:49:39 | 只看該作者
32#
發(fā)表于 2025-3-27 03:13:02 | 只看該作者
33#
發(fā)表于 2025-3-27 06:19:24 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewe fairly clear. Antihypertensive drugs are approved on the basis of a demonstrated ability to lower blood pressure to a reasonable degree and a reasonably complete characterization of a drug’s pharmacokinetic and pharmacodynamic properties, with particular emphasis on dose-response and on patient ch
34#
發(fā)表于 2025-3-27 12:24:55 | 只看該作者
35#
發(fā)表于 2025-3-27 15:36:50 | 只看該作者
36#
發(fā)表于 2025-3-27 20:24:27 | 只看該作者
37#
發(fā)表于 2025-3-27 21:56:05 | 只看該作者
0166-9842 al and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering
38#
發(fā)表于 2025-3-28 03:02:29 | 只看該作者
39#
發(fā)表于 2025-3-28 06:40:30 | 只看該作者
What Should be Required for FDA Approvability of a New Antihypertensive Drug? What is the FDA’s Viewaracteristics that can alter this response. We have not, up to now, sought evidence of diminished end-organ damage or mortality for each new agent, relying instead on the past studies that showed such benefits of lowering blood pressure.
40#
發(fā)表于 2025-3-28 13:46:51 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 04:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
邓州市| 儋州市| 若尔盖县| 西贡区| 镇雄县| 南岸区| 镇赉县| 崇阳县| 府谷县| 龙胜| 洱源县| 苏尼特右旗| 滕州市| 山丹县| 杭锦后旗| 黄山市| 陆川县| 临沂市| 霍林郭勒市| 体育| 夏津县| 广德县| 启东市| 扬州市| 兖州市| 普洱| 汽车| 榆社县| 伊宁县| 云梦县| 合川市| 泊头市| 扶沟县| 长治县| 西昌市| 陆丰市| 昔阳县| 南康市| 嘉兴市| 揭阳市| 伊宁市|